Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1130886

registered interest
date	10/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dementia
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what comparative estimate his Department has made of the average cost of (a) caring for a dementia patient at home with care provided by family and (b) care provided in an in-patient setting.
tabling member constituency	Birmingham, Selly Oak
tabling member printed	Steve McCabe
uin	262230
answer	answer is ministerial correction date of answer 13/06/2019 answer text <p>The Department has made no such comparative estimate.</p><p>The average cost of caring for a dementia patient at home by family is not collected or reported centrally.</p><p>Data on the average cost of care provided in an in-patient setting is not available in the format requested.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 13/06/2019 13:33:32 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	298 label Biography information for Steve McCabe

1129267

registered interest
date	03/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Counselling: Sign Language
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the availability of deaf-focused NHS counselling using British sign language as the first language in England; and if he will make a statement.
tabling member constituency	Birmingham, Selly Oak
tabling member printed	Steve McCabe
uin	258973
answer	answer is ministerial correction date of answer 06/06/2019 answer text <p>The National Health Service Improving Access to Psychological Therapies (IAPT) programme is available to all adults. If an individual is deaf and requires British Sign Language (BSL) to be used, services can either use a BSL interpreter or refer them to Sign Health, an IAPT service which delivers therapy using BSL trained therapists. Sign Health is available nationally but is funded via individual funding requests, so clinical commissioning groups (CCGs) are responsible for funding decisions. In 2018/19 Sign Health received £1 million from 116 CCGs for the treatment of around 250 people. Other alternatives that may be suitable for deaf people include therapy delivered via a digital route, for example text messaging.</p><p>The NHS England IAPT manual, published in June 2018, specifies that commissioners, managers, primary and secondary care clinicians should develop local IAPT care pathways in consultation with patient groups and community leaders, including under-represented groups. The IAPT manual recommends that commissioners and providers consider commissioning services that have bilingual clinicians who speak the language of local minority groups, including clinicians who are fluent in BSL for deaf people.</p><p>Local commissioners have to pay due regard to the equality legislation when commissioning IAPT services. They are able to decide whether they meet their responsibilities through services who provide BSL trained therapists or through interpreters in their locality.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 06/06/2019 16:11:41 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	298 label Biography information for Steve McCabe

1129268

registered interest
date	03/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Counselling: Sign Language
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, who is responsible for commissioning deaf-focused NHS counselling using British sign language counsellors.
tabling member constituency	Birmingham, Selly Oak
tabling member printed	Steve McCabe
uin	258974
answer	answer is ministerial correction date of answer 11/06/2019 answer text <p>NHS England commissions specialised mental health services for children, young people and adults who are deaf. These include inpatient and outreach services for children and young people and services for adults who require inpatient care, including care in secure mental health services.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 11/06/2019 14:38:55 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	298 label Biography information for Steve McCabe

1088498

registered interest
date	13/03/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments: Technology
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the regional variation in the uptake of MedTech products across the NHS.
tabling member constituency	Birmingham, Selly Oak
tabling member printed	Steve McCabe
uin	231898
answer	answer is ministerial correction date of answer 21/03/2019 answer text <p>Through the Accelerated Access Review, the NHS Long Term Plan and the second Life Sciences Sector Deal, the Government and the National Health Service have confirmed their commitment that, where appropriate, all patients should be able to benefit from the best treatments as fast as possible. To deliver on this, we have announced a number of measures to improve the spread of health tech innovations:</p><p> </p><p>- Strengthening the Innovation Scorecard, the national tool that measures the uptake of cost effective innovations approved by the National Institute for Health and Care Excellence (NICE), and widening the range of medtech products it covers;</p><p>- From 2020, a new NHS England health tech funding requirement will identify the best value innovations as ‘ready to spread’ and help the NHS to adopt them quickly. This will apply to health tech products assessed as cost saving by NICE. In addition, NICE will significantly increase the number of evaluations it does for health tech products, so that the NHS has the evidence it needs to decide the best products to adopt and spread;</p><p>- The Accelerated Access Collaborative, under the chairmanship of Lord Darzi, will be expanded to be the umbrella organisation across the innovation landscape in the United Kingdom, tackling the system wide-barriers that cause unwarranted variation in the level of access for patients;</p><p>- The regional network of Academic Health Science Networks (AHSNs) will also continue to be a key partner in adoption and spread of health technology. AHSNs bring together the assets in their regions to drive innovation uptake and support local service transformation, promoting health equality, best practice and transformation in leadership, quality and safety of care; and</p><p>- These approaches build on NHS Improvement’s Getting It Right First Time and NHS RightCare initiatives, which seek to improve the quality of care within the NHS by reducing unwarranted variation.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 21/03/2019 12:15:58 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	298 label Biography information for Steve McCabe

1027630

registered interest
date	18/12/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what his Department's policy is on the recommendations in relation to the provision of information on industry (a) activities, (b) risks, (c) costs and (d) returns on R&D made in the report on Pharmaceutical Innovation and Access to Medicines, published by the OECD in November 2018.
tabling member constituency	Birmingham, Selly Oak
tabling member printed	Steve McCabe
uin	203274
answer	answer is ministerial correction date of answer 21/12/2018 answer text <p>We note the report ‘Pharmaceutical Innovation and Access to Medicines’ published by the Organisation for Economic Co-operation and Development (OECD) in November 2018 and agree with the recommendation that a more informed debate on the cost and benefits of research and development would be beneficial. The OECD’s work through the papers published by the health division of the Directorate of Labour and Social Affairs is a welcome contribution to that debate and we look forward to future publications from them.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 21/12/2018 13:55:33 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	298 label Biography information for Steve McCabe